INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 September 2010
Total net assets |
£96.1m |
NAV per share |
159.8p |
Share price |
132.8p |
Total value of unquoted investments |
£22.7m |
Total number of portfolio companies |
58 |
Cash |
(1)% NAV |
Cash committed and reserved to unquoted investments |
0% NAV |
Portfolio companies with < 1 year of cash |
8% NAV |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
6.25 |
Amgen |
5.67 |
Micromet |
5.49 |
Shire Ltd |
5.09 |
Alexion Pharmaceuticals |
4.87 |
Gilead Sciences |
4.82 |
Teva |
3.61 |
Genzyme |
3.44 |
Cadent |
3.32 |
Incyte |
3.06 |
|
----------- |
Total |
45.62 |
Geographical Allocation |
% |
United States |
77 |
Europe |
23 |
Australia |
1 |
Cash |
(1) |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
78 |
Unquoted |
23 |
Cash |
(1) |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
22 OCTOBER 2010